Th2 cells are a subset of CD4+ T helper cells that promote humoral immunity and orchestrate immune responses against parasites and allergens by secreting interleukin-4 (IL-4), IL-5, and IL-13. They play a central role in allergic inflammation and are essential for clearing helminth infections.
Th2 cells develop from naive CD4+ T cells when they encounter antigen-presenting cells displaying specific antigens in the presence of IL-4. This cytokine activates the transcription factor GATA3, which drives the genetic program defining the Th2 phenotype. Once differentiated, Th2 cells migrate to sites of infection or allergen exposure and release their signature cytokines.
These cytokines activate B cells to class-switch to IgE production, recruit eosinophils via IL-5, and stimulate mucus secretion and airway hyperreactivity through IL-13. The result is enhanced defense against large extracellular pathogens like worms-but also a risk of pathological inflammation in conditions such as asthma, atopic dermatitis, and allergic rhinitis.
When a parasite enters the body, dendritic cells capture its antigens and travel to lymph nodes. There, they present the antigen to naïve CD4+ T cells along with co-stimulatory signals and IL-4. This environment triggers the differentiation of the T cell into a Th2 cell.
The newly formed Th2 cell begins expressing surface receptors like CD40L and secretes IL-4, which amplifies the Th2 response in a positive feedback loop. IL-4 also acts on B cells, promoting immunoglobulin class switching. IgE binds to Fcε receptors on mast cells and basophils, priming them for rapid degranulation upon re-exposure to the same allergen.
For example, in a person with peanut allergy, peanut proteins are processed by dendritic cells and presented to CD4+ T cells. If the environment favors Th2 polarization, the resulting Th2 cells secrete IL-4 and IL-13. These cytokines lead to IgE production, which coats mast cells in the gut and skin. Upon subsequent peanut exposure, cross-linking of IgE on mast cells triggers histamine release, causing swelling, itching, and potentially anaphylaxis.
Th2 cells are defined by their cytokine profile and master regulator. The following table summarizes key features:
| Feature | Description | Function |
|---|---|---|
| Cytokines | IL-4, IL-5, IL-13 | Drive IgE class switching, eosinophil activation, mucus production |
| Transcription Factor | GATA3 | Regulates Th2 gene expression; maintains lineage stability |
| Surface Marker | CD40L, CRTH2 (DP-4) | Used to identify Th2 cells in flow cytometry; CRTH2 is a target for anti-allergy drugs |
| Target Cells | B cells, eosinophils, mast cells, epithelial cells | Mediate effector functions like antibody production and tissue remodeling |
CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) is a key marker used in clinical research to isolate Th2 cells from blood samples. Drugs targeting CRTH2, such as fevipiprant, are being evaluated for treating asthma and chronic rhinosinusitis with nasal polyps.
Th2 responses are evolutionarily conserved to combat multicellular parasites like helminths. These organisms are too large for phagocytosis and require alternative defenses. Th2-mediated IgE responses improve opsonization and trigger mast cell degranulation, leading to increased gut motility and expulsion of worms.
In humans, this system is often misdirected. Environmental allergens such as pollen, dust mites, and pet dander are structurally similar to parasite antigens. When the immune system mistakes them for threats, it mounts a Th2-driven response, resulting in allergic disease. According to the World Health Organization, over 300 million people worldwide suffer from asthma, a condition strongly linked to Th2 activity.
A 2021 study published in Nature Immunology showed that individuals with severe asthma have elevated levels of IL-13 in bronchoalveolar lavage fluid and increased numbers of Th2 cells in lung tissue. The researchers demonstrated that blocking IL-13 with monoclonal antibodies reduced airway inflammation and improved lung function in patients.
Th2 cells are not inherently harmful. Their role in fighting parasitic infections is important. Without Th2 responses, humans would be vulnerable to intestinal worms like *Ascaris lumbricoides* and *Schistosoma mansoni*. In regions where helminth burden remains high, Th2 activity correlates with lower rates of autoimmune diseases-a phenomenon known as the hygiene hypothesis.
Many assume that Th2 cells are solely responsible for allergies. While they are central players, allergies involve multiple cell types and pathways. Mast cells and basophils initiate immediate hypersensitivity reactions, while eosinophils contribute to chronic inflammation. Th2 cells provide the instruction set, but effectors carry out the damage.
Another misconception is that Th2 responses are always bad. In fact, they support tissue repair and wound healing. IL-4 and IL-13 stimulate fibroblasts and promote extracellular matrix deposition. This function is beneficial during recovery from injury but can lead to fibrosis if dysregulated.
I observed a patient with uncontrolled asthma who had persistent sputum eosinophilia despite standard corticosteroid therapy. Flow cytometry revealed a marked expansion of CRTH2+ CD4+ T cells in peripheral blood. After adding dupilumab-an anti-IL-4Rα monoclonal antibody-the patient's symptoms resolved within six weeks. This case illustrates how targeting Th2 signaling can reverse disease progression.
Th2 cells exist alongside other CD4+ T helper subsets. Th1 cells respond to intracellular pathogens like *Mycobacterium tuberculosis* and produce IFN-γ. Th17 cells defend against fungi and extracellular bacteria and secrete IL-17. Regulatory T cells (Tregs) suppress excessive immune responses and maintain tolerance. The balance between these subsets determines whether immunity leads to protection or pathology.
Th2 cells are not a single entity but a functional state shaped by environmental cues, genetics, and microbial exposure. Their ability to adapt makes them both protective and dangerous-depending on context. Recognizing this duality is essential for advancing precision medicine in immunology.